These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 5663195)

  • 1. Cardiovascular laboratory Duke Hospital.
    Parmley WW; Sonnenblick EH
    N Engl J Med; 1968 Aug; 279(8):435. PubMed ID: 5663195
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular effects of various administration forms of glucagon].
    Lydtin H; Leidl L; Schewe S; Daniel W; Schierl W; Lohmöller G
    Verh Dtsch Ges Inn Med; 1972; 78():1551-4. PubMed ID: 4665606
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin.
    Isbil-Buyukcoskun N; Gulec G
    Regul Pept; 2004 Apr; 118(1-2):33-8. PubMed ID: 14759554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary effect of glucagon on positive chronotropism.
    Kimura T; Kokubun M; Hashimoto K
    Jpn J Pharmacol; 1974 Apr; 24(2):279-83. PubMed ID: 4546888
    [No Abstract]   [Full Text] [Related]  

  • 5. An experimental evaluation of the reputed influence of thyroxine on the cardiovascular effects of catecholamines.
    van der Schoot JB; Moran NC
    J Pharmacol Exp Ther; 1965 Sep; 149(3):336-45. PubMed ID: 5848044
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of glucagon on heart.
    Ramo BW
    N Engl J Med; 1968 Aug; 279(8):435. PubMed ID: 5663194
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of hormones and chemical mediators on some functional parameters of the rabbit heart. V. Effect of glucagon].
    Macrì I; Rigon-Macrì P; Scaliti GV
    Boll Soc Ital Biol Sper; 1974 Nov; 50(21):1873-7. PubMed ID: 4462776
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucagon as a myocardial stimulant.
    Drug Ther Bull; 1970 Oct; 8(20):77-9. PubMed ID: 5487969
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular profile of mixidine fumarate, a compound which attenuates myocardial chronotropic responses.
    Pruss TP; Hageman WE; Jacoby HI
    J Pharmacol Exp Ther; 1980 Mar; 212(3):514-8. PubMed ID: 7359351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of k-strophanthin on the hemodynamics of the dog heart in a closed thorax].
    Simon H; Turina M; Fricke G; Medici T; Krayenbühl HP; Lüthy E
    Arzneimittelforschung; 1969 May; 19(5):697-701. PubMed ID: 5819776
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of ouabagenin on the hemodynamics of the dog heart in a closed thorax].
    Simon H; Fricke G; Turina M; Noseda G; Krayenbühl HP; Lüthy E
    Arzneimittelforschung; 1969 May; 19(5):693-7. PubMed ID: 5819775
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of glucagon on amitriptyline-induced cardiovascular toxicity in rats.
    Kaplan YC; Hocaoglu N; Oransay K; Kalkan S; Tuncok Y
    Hum Exp Toxicol; 2008 Apr; 27(4):321-5. PubMed ID: 18684803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peripheral circulatory modifications after glucagon administration].
    Lefebvre P; Beaujean M
    Arch Int Physiol Biochim; 1964 Jan; 72(1):9-16. PubMed ID: 4157799
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999).
    Aramendía P; Kaumann AJ
    J Pharmacol Exp Ther; 1967 Feb; 155(2):259-66. PubMed ID: 6025517
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of glucagon on arrhythmias induced by coronary artery occlusion and ouabain in dogs.
    Singh J; Bala S; Kaur AH; Garg KN
    Indian J Physiol Pharmacol; 1980; 24(4):329-34. PubMed ID: 7216388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and neuromuscular effects of Org NC 45, pancuronium, metocurine, and d-tubocurarine in dogs.
    Booij LH; Edwards RP; Sohn YJ; Miller RD
    Anesth Analg; 1980 Jan; 59(1):26-30. PubMed ID: 7188662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).
    Rowe GG; McKenna DH; Sialer S; Corliss RJ
    Vasc Dis; 1967 Jun; 4(3):183-90. PubMed ID: 6028828
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypotensive effect of glucagon in rats and dogs.
    Singh J; Bala S; Kaur AH; Garg KN
    Indian J Physiol Pharmacol; 1980; 24(3):249-50. PubMed ID: 7461809
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of octapressin on the general and coronary circulation in anesthetized, closed chest dogs].
    Strauer BE; Reploh HD; Cott L; Tauchert M; Bretschneider HJ
    Arztl Forsch; 1969 Jul; 23(7):227-35. PubMed ID: 5820305
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of gastric peristalsis inhibition by scopolamine butylbromide and glucagon: evaluation by electrogastrography and analysis of heart rate variability.
    Katoh K; Nomura M; Iga A; Hiasa A; Uehara K; Harada K; Nakaya Y; Ito S
    J Gastroenterol; 2003; 38(7):629-35. PubMed ID: 12898354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.